Your browser doesn't support javascript.
loading
Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
Taylor, D N; Cárdenas, V; Sanchez, J L; Bégué, R E; Gilman, R; Bautista, C; Perez, J; Puga, R; Gaillour, A; Meza, R; Echeverria, P; Sadoff, J.
Affiliation
  • Taylor DN; Dept. of Enteric Infections, Division of Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA. David.Taylor@na.amedd.army.mil.
J Infect Dis ; 181(5): 1667-73, 2000 May.
Article in En | MEDLINE | ID: mdl-10823767
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cholera Vaccines / Vaccines, Synthetic / Cholera / Cholera Toxin Type of study: Clinical_trials / Screening_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Middle aged Country/Region as subject: America do sul / Peru Language: En Journal: J Infect Dis Year: 2000 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cholera Vaccines / Vaccines, Synthetic / Cholera / Cholera Toxin Type of study: Clinical_trials / Screening_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Middle aged Country/Region as subject: America do sul / Peru Language: En Journal: J Infect Dis Year: 2000 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos